DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | A211491 | SUN PHARMACEUTICAL INDUSTRIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
AstraZeneca AB v. Sun Pharmaceutical Industries Limited et al 1 patentANDA 211491dapagliflozin/metformin hydrochloride | D. Del. | 2023-12-04 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Code | Date | Status |
|---|---|---|
| PC | Oct 3, 2026 | < 1 year |
New: New record
Sun Pharma's dapagliflozin and metformin hydrochloride combination (NDA 211491) gained pediatric exclusivity, extending regulatory protection for the fixed-dose combination.
New: New record
New: New record